No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
RORgamma antagonists are a type of immune disorder drug used to treat a variety of conditions, including autoimmune diseases, inflammatory diseases, and allergies. These drugs work by blocking the activity of the RORgamma protein, which is involved in the regulation of the immune system. By blocking the activity of this protein, RORgamma antagonists can reduce inflammation and help to control the immune system.
RORgamma antagonists are a relatively new class of drugs, and their use is increasing as more research is conducted into their potential benefits. They are generally well-tolerated and have few side effects, making them an attractive option for treating immune disorders.
Companies in the RORgamma antagonist market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
